Euclidean Technologies letter to investors for the first quarter ended March 2019, titled, “The Euclidean Fund For Cancer Research.” Q1 hedge fund letters, conference, scoops etc The equity market’s sharp rebound from last year’s late drop reflects just how much […] The post Euclidean 1Q19 Letter appeared first on ValueWalk.